Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection (CAPOGA): A Large Multicenter Phase III Randomized Controlled Trial

NCT03817268 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Anhui Medical University as lead sponsor.

NCT NCT03817268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection (CAPOGA): A Large Multicenter Phase III Randomized Controlled Trial
Lead sponsor
The First Affiliated Hospital of Anhui Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
January 16, 2019
Completion date
January 30, 2026
Enrollment
768 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer